Search
NT Pharma Jumps Almost 14% on New Share Issuance for AI Medical Business Acquisition
2025-04-29 /
Read about 0 minute
Author：小编
NT Pharma witnessed a nearly 14% surge in its share price following the announcement of its plans to acquire an AI medical business through the issuance of new shares. The company intends to indirectly acquire a 58.11% stake in Zhejiang Kangyuan Medical Devices for RMB 116 million. Notably, the issue price represents a 22.41% discount compared to the previous trading day's closing price. Zhejiang Kangyuan specializes in the research, development, and operation of X-ray robotic bone densitometry systems and portable digital X-ray diagnostic robotic systems, and holds pertinent patents in these areas.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
